239 Stock Overview
Pak Fah Yeow International Limited, an investment holding, manufactures, markets, and distributes healthcare products under the Hoe Hin brand name in the People’s Republic of China, Hong Kong, Macau, Southeast Asia, North America, the United Kingdom, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Pak Fah Yeow International Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$2.01 |
| 52 Week High | HK$2.20 |
| 52 Week Low | HK$1.24 |
| Beta | 0.19 |
| 1 Month Change | -7.37% |
| 3 Month Change | 15.52% |
| 1 Year Change | 41.55% |
| 3 Year Change | 10.44% |
| 5 Year Change | -33.00% |
| Change since IPO | 330.72% |
Recent News & Updates
Recent updates
Here's Why We Think Pak Fah Yeow International (HKG:239) Might Deserve Your Attention Today
Nov 21
Estimating The Intrinsic Value Of Pak Fah Yeow International Limited (HKG:239)
Aug 31Calculating The Intrinsic Value Of Pak Fah Yeow International Limited (HKG:239)
Jun 01Does Pak Fah Yeow International (HKG:239) Have A Healthy Balance Sheet?
Dec 12Pak Fah Yeow International's (HKG:239) Shareholders Will Receive A Smaller Dividend Than Last Year
Sep 02The Strong Earnings Posted By Pak Fah Yeow International (HKG:239) Are A Good Indication Of The Strength Of The Business
Sep 24Pak Fah Yeow International (HKG:239) Will Pay A Larger Dividend Than Last Year At HK$0.028
Aug 28Estimating The Intrinsic Value Of Pak Fah Yeow International Limited (HKG:239)
May 11Consider This Before Buying Pak Fah Yeow International Limited (HKG:239) For The 2.9% Dividend
Feb 21What Type Of Returns Would Pak Fah Yeow International's(HKG:239) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Dec 17
How Does Pak Fah Yeow International Limited (HKG:239) Fare As A Dividend Stock?
Nov 21Shareholder Returns
| 239 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | -2.0% | 1.8% | 2.3% |
| 1Y | 41.5% | -17.4% | -10.9% |
Return vs Industry: 239 exceeded the Hong Kong Pharmaceuticals industry which returned -17.4% over the past year.
Return vs Market: 239 exceeded the Hong Kong Market which returned -10.9% over the past year.
Price Volatility
| 239 volatility | |
|---|---|
| 239 Average Weekly Movement | 4.5% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 14.5% |
| 10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 239 has not had significant price volatility in the past 3 months.
Volatility Over Time: 239's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1927 | 102 | Wee Sean Gan | www.pakfahyeow.com |
Pak Fah Yeow International Limited, an investment holding, manufactures, markets, and distributes healthcare products under the Hoe Hin brand name in the People’s Republic of China, Hong Kong, Macau, Southeast Asia, North America, the United Kingdom, and internationally. It operates through three segments: Healthcare, Property Investments, and Treasury Investments. The company offers white flower embrocation medicated oils, strain relief products, and ointments under, as well as Fúzai 239, a floral-scented white flower embrocation.
Pak Fah Yeow International Limited Fundamentals Summary
| 239 fundamental statistics | |
|---|---|
| Market cap | HK$626.40m |
| Earnings (TTM) | HK$105.04m |
| Revenue (TTM) | HK$259.56m |
6.0x
P/E Ratio2.4x
P/S RatioIs 239 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 239 income statement (TTM) | |
|---|---|
| Revenue | HK$259.56m |
| Cost of Revenue | HK$40.72m |
| Gross Profit | HK$218.84m |
| Other Expenses | HK$113.80m |
| Earnings | HK$105.04m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.34 |
| Gross Margin | 84.31% |
| Net Profit Margin | 40.47% |
| Debt/Equity Ratio | 0.6% |
How did 239 perform over the long term?
See historical performance and comparisonDividends
10.2%
Current Dividend Yield20%
Payout RatioDoes 239 pay a reliable dividends?
See 239 dividend history and benchmarks| Pak Fah Yeow International dividend dates | |
|---|---|
| Ex Dividend Date | Jul 08 2024 |
| Dividend Pay Date | Aug 12 2024 |
| Days until Ex dividend | 74 days |
| Days until Dividend pay date | 109 days |
Does 239 pay a reliable dividends?
See 239 dividend history and benchmarks